Wockhardt Denies Stake-Sale Speculation, Stock Pares Its Gains

Wockhardt Ltd. pared gains of as much as 18 percent today after the Indian generic drugmaker said it doesn’t plan to sell a stake.

The stock rose 14 percent to 749.35 rupees at the close in Mumbai, still the most since April 2. The initial gains were triggered by speculation of a stake sale, said Arun Kejriwal, director at Kejriwal Research & Investment in Mumbai.

“There’s no question of selling stake,” Dominic D’Souza, a spokesman for Wockhardt, said in a phone interview today. “We strongly deny the rumor.”

Global companies invested about 280 billion rupees ($4.66 billion) in Indian drugmakers in the three years through 2013 to gain greater control over factories that supply the lucrative U.S. market, data from the Ministry of Commerce show. The S&P BSE Healthcare Index has tripled in value in the past five years, outpacing the 62 percent gain in the benchmark S&P BSE Sensex.

Shares of Mumbai-based have jumped 66 percent this year, faster than the 23 percent climb in the Sensex. The stock’s 10-day volatility rose to 56.5, the highest since June 9, amid volume that was 9.6 times the daily three-month average, the data show.

“We are advising investors to avoid the stock for now as there’s too much volatility,” said Kejriwal.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE